Genesis MedTech Gains EU Entry for Its Next-Gen Ultrasonic Surgical Tool

SINGAPORE – June 02, 2026 – Genesis MedTech Group has secured a critical gateway into the European healthcare market. The company’s surgical division, Reach Surgical, announced it has received CE Mark approval for its SOUND REACH™ Swift, a next-generation ultrasonic shear designed to enhance precision and efficiency in open surgery. This regulatory milestone allows the device to be commercialized across the European Union, targeting high-demand procedures such as breast and thyroid surgeries.

The SOUND REACH™ Swift is not just another instrument; it represents a significant rethink of how ultrasonic energy devices are designed and used in the operating room. Its approval signals a strategic move by the Singapore-based company to challenge established players in the lucrative European surgical device market.

Redefining the Surgical Workflow

At the core of the SOUND REACH™ Swift's innovation is its all-in-one, 'plug-and-play' design. Unlike traditional ultrasonic systems that often require surgeons or their staff to assemble a separate transducer handpiece onto the instrument before use, the Swift integrates a custom, lightweight transducer directly into the device. This single-unit construction eliminates a time-consuming and often cumbersome step in preoperative preparation, along with the associated logistical challenges of managing and sterilizing separate components.

"A 'plug-and-play' device that reduces setup time and cognitive load in the OR is a significant value proposition," noted one surgical technology analyst. "Surgeons want tools that are not only clinically effective but also simple to integrate into their fast-paced workflow."

This focus on ergonomic efficiency extends to the instrument's functionality. Featuring a forceps-style design familiar to surgeons who perform open procedures, the Swift combines multiple functions into a single tool. It allows for tissue grasping, precise dissection, and reliable coagulation without needing to switch instruments. This multi-functionality can reduce procedural time and minimize disruptions, allowing the surgeon to maintain focus on the delicate task at hand.

Furthermore, the device is engineered to be compact and lightweight, a direct response to the physical demands placed on surgeons during prolonged operations. By reducing hand fatigue, the design aims to improve maneuverability and maintain consistency, which is crucial when working for hours in constrained anatomical areas.

A Strategic Entry into the European Arena

The CE Mark is more than a regulatory checkbox; it is a passport to the highly competitive and regulated European market. For Genesis MedTech, this approval represents a major step in its global expansion strategy, enabling it to go head-to-head with industry giants like Johnson & Johnson's Ethicon division, whose HARMONIC™ line of ultrasonic shears has long been a market leader.

While established products like the HARMONIC™ 1100 Shears boast capabilities such as sealing vessels up to 7mm, SOUND REACH™ Swift is engineered for reliable coagulation of vessels up to 5mm, a specification well-suited for its target procedures. Reach Surgical appears to be carving out its competitive advantage not by overpowering incumbents on every metric, but by focusing on a holistic user experience centered on simplicity, ergonomics, and workflow integration.

This launch is part of a broader, aggressive growth strategy for Genesis MedTech. Founded in 2019, the company has rapidly built a global footprint and a diverse portfolio spanning surgical, cardiology, and vascular interventions. Recent Series B funding has been earmarked for accelerating R&D and commercialization, with a clear focus on penetrating global markets. The approval of the Swift, following another recent CE mark for its iREACH IRIS powered stapling platform, demonstrates a sustained momentum and a commitment to building a comprehensive suite of advanced surgical tools.

Addressing a Growing Clinical Need

The timing of this European launch aligns with a pressing global health trend: the rising incidence of breast and thyroid cancers. According to GLOBOCAN 2022 estimates, the world saw 2.3 million new breast cancer cases and over 821,000 new thyroid cancer cases. This growing disease burden fuels demand for technologies that can make these common, yet delicate, surgeries safer and more effective.

Thyroid and breast surgeries often require meticulous dissection in confined spaces, surrounded by critical nerves and blood vessels. In thyroidectomies, for example, preserving the recurrent laryngeal nerve is paramount to protecting a patient's voice. In breast cancer surgery, precise tissue removal is balanced against the need to preserve healthy tissue for oncoplastic reconstruction.

This is where the technical specifications of SOUND REACH™ Swift become clinically significant. Its fine curved-tip blade is designed for precise dissection, while its ultrasonic technology provides controlled energy delivery and effective thermal management. This minimizes thermal spread to adjacent tissues, a critical factor in protecting delicate structures. The ability to reliably coagulate and seal vessels helps maintain a clear surgical field and reduces blood loss, contributing to better patient outcomes.

The Evolution of Open Surgery in a Minimally Invasive World

While much of the recent buzz in surgical innovation has focused on robotics and minimally invasive surgery (MIS), open surgery remains a cornerstone of modern medicine. For many complex cancer cases, specific patient anatomies, or in healthcare systems with limited access to robotic platforms, traditional open approaches are still the standard of care.

However, 'traditional' does not mean static. The field of open surgery is continuously evolving, with a strong push towards improving outcomes, reducing patient trauma, and enhancing efficiency. Innovations like Minimally Invasive Video-Assisted Thyroidectomy (MIVAT) and scar-free endoscopic approaches are gaining traction, but they have not replaced the need for open procedures.

SOUND REACH™ Swift fits perfectly into this narrative of modernizing established surgical practice. It demonstrates that significant innovation is still happening in the open surgery space. By integrating advanced energy delivery, superior ergonomics, and a simplified workflow into a tool for traditional procedures, Genesis MedTech is helping to elevate the standard of care for a vast number of patients who undergo open surgery every day. This approach aligns directly with the company's stated mission of 'Making Better Healthcare Happen' by developing technologies that make treatments not only less invasive but also more accessible and effective at scale.